<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>cc7042</ui>
   <ji>CCJ</ji>
   <fm>
      <dochead>Poster presentation</dochead>
      <bibl>
         <title>
            <p>Eosinophilia as a marker of adrenal insufficiency in critically ill patients with severe septic shock: 1-year prospective study</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Mouloudi</snm>
               <fnm>Eleni</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Katsanoulas</snm>
               <fnm>Constantine</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Vrochides</snm>
               <fnm>Dionysios</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A4">
               <snm>Giasnetsova</snm>
               <fnm>Tatiana</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A5">
               <snm>Papageorghiou</snm>
               <fnm>Chryssoula</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A6">
               <snm>Gritsi-Gerogianni</snm>
               <fnm>Nikoletta</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Intensive Care Unit Department, Hippokrateion Hospital, Thessaloniki, Greece</p>
            </ins>
         </insg>
         <source>Critical Care</source>
         <supplement>
            <title>
               <p>Sepsis 2008</p>
            </title>
            <editor>Steven Opal, Tom van der Poll, John Marshall and Konrad Reinhart</editor>
            <note>Meeting abstracts</note>
            <url>http://ccforum.com/supplements/notes/ccv12s5-info.pdf</url>
         </supplement>
         <conference>
            <title>
               <p>Sepsis 2008</p>
            </title>
            <location>Granada, Spain</location>
            <date-range>19&#8211;22 November 2008</date-range>
            <url>http://www.sepsisforum.org</url>
         </conference>
         <issn>1364-8535</issn>
         <pubdate>2008</pubdate>
         <volume>12</volume>
         <issue>Suppl 5</issue>
         <fpage>P9</fpage>
         <url>http://ccforum.com/content/12/S5/P9</url>
         <xrefbib>
            <pubid idtype="doi">10.1186/cc7042</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>18</day>
               <month>11</month>
               <year>2008</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2008</year>
         <collab>Mouloudi et al; licensee BioMed Central Ltd.</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Background</p>
         </st>
         <p>Adequate adrenocortical function is essential to survive critical illness. The number of circulating eosinophils has been proposed as a marker of adrenocortical function. The goal of the present study was to determine whether eosinophilia could serve as a useful and early marker of adrenal insufficiency in critically ill patients with severe septic shock.</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>During a 1-year period, we studied prospectively all 294 patients admitted to our ICU. Sixteen patients (13 male/three female, 5.4% of admissions) with eosinophilia defined as more than 3% of the white blood cell count and severe septic shock, refractory to fluid and vasopressor resuscitation, were included. A high-dose (250 &#956;g, intravenously) corticotropin stimulation test was performed in all included patients.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>The mean age was 47.2 &#177; 18.7 years, the Acute Physiology and Chronic Health Evaluation II score on admission day was 18.6 &#177; 6.8 and the Sepsis-related Organ Failure Assessment score was 10.3 &#177; 2.7 on eosinophilia day. The mean eosinophil count was 6.9 &#177; 3.5% of white blood cells. Eosinophilia was present 1.9 &#177; 0.9 days (range 8 hours to 4 days) before the onset of septic shock. Multidrug-resistant Gram-negative bacteria in 14 patients, Gram-positive in three patients and fungi in two patients were isolated and considered responsible for sepsis. Baseline cortisol levels were 19.4 &#177; 8.1 &#956;g/dl and the adrenal response to the corticotropin stimulation test was 8.3 &#177; 4.9 &#956;g/dl above baseline. Eleven out of 16 patients failed to respond to the corticotropin stimulation test above the critical level of a 9 &#956;g/dl rise, and two out of 16 patients had baseline cortisol concentration &lt;10 &#956;g/dl. A hydrocortisone infusion (300 mg/day) treatment resulted in haemodynamic improvement in 12 out of 16 patients (75%). The 28-day mortality (following the onset of septic shock) was 43.7%. The only independent predictor of death was age (<it>P </it>= 0.027).</p>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p>Relative eosinophilia may be considered a useful and early bioassay for adrenocortical function assessment in critically ill patients with severe septic shock and assumed adrenocortical depression.</p>
      </sec>
   </bdy>
</art>

